Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2022; 18
DOI: 10.1055/s-0045-1811220
SKIN TUMORS AND SARCOMAS

BONE METASTASIS AS AN INDEPENDENT PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH IMMUNE CHECKPOINT BLOCKADE

Authors

  • Marcos Rezende de Jesus Teixeira

    1   ONCOMED

  • Milton Jose de Barros e Silva

    1   ONCOMED

  • Natasha Carvalho Pandolfi

    1   ONCOMED

  • José Augusto Rinck Junior

    1   ONCOMED

  • Thiago Bueno de Oliveira

    1   ONCOMED

  • Monique Celeste Tavares

    1   ONCOMED

  • João Paulo da Silveira Nogueira Lima

    1   ONCOMED

  • João Pedreira Duprat Neto

    1   ONCOMED
Weitere Informationen
  Alle Artikel dieser Rubrik

Keywords:

melanoma - Immunotherapy - Bone metastasis


Publikationsverlauf

Artikel online veröffentlicht:
03. November 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Bibliographical Record
Marcos Rezende de Jesus Teixeira, Milton Jose de Barros e Silva, Natasha Carvalho Pandolfi, José Augusto Rinck, Thiago Bueno de Oliveira, Monique Celeste Tavares, João Paulo da Silveira Nogueira Lima, João Pedreira Duprat Neto. BONE METASTASIS AS AN INDEPENDENT PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH IMMUNE CHECKPOINT BLOCKADE. Brazilian Journal of Oncology 2022; 18.
DOI: 10.1055/s-0045-1811220